Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc.

$0.90 -0.05 (-5.53%)
Market Cap
$264.47M
Shares
277.11M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Pick a completed quarter in the Quarter selector below to see a single quarter with position changes.
Holders: 177
Total Value: $133,511,056
Total Shares: 99,791,633
Showing 1–100 of 183 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 171 13F filers
Top Holder
19.2%
Jun 2023 → Mar 2026 · range 15.5% – 40.8%
of institutional value
Top 5
52.9%
Jun 2023 → Mar 2026 · range 46.7% – 76.9%
of institutional value
Top 10
65.6%
Jun 2023 → Mar 2026 · range 60.9% – 88.1%
of institutional value
HHI
768
Jun 2023 → Mar 2026 · range 627 – 2,181
Broadly held
Showing 100 of 183
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 53 filings 53 filers Visit website Investor relations